These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 18545147)

  • 1. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle cell neoplasm of skin: diagnostic dilemma.
    Jain M; Singh S; Agarwal K
    Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
    Jensen K; Wilkinson B; Wines N; Kossard S
    J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
    Monteagudo C; Calduch L; Navarro S; Joan-Figueroa A; Llombart-Bosch A
    Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma: a clinicopathological study of 89 cases.
    Mirza B; Weedon D
    Australas J Dermatol; 2005 Nov; 46(4):235-8. PubMed ID: 16197421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keloidal atypical fibroxanthoma: a case series.
    Kim J; McNiff JM
    J Cutan Pathol; 2009 May; 36(5):535-9. PubMed ID: 19476521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical fibroxanthoma with lymphomatoid reaction.
    Zheng R; Ma L; Bichakjian CK; Lowe L; Fullen DR
    J Cutan Pathol; 2011 Jan; 38(1):8-13. PubMed ID: 21039743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.